Literature DB >> 30821120

Buccal fat pad-derived stem cells with anorganic bovine bone mineral scaffold for augmentation of atrophic posterior mandible: An exploratory prospective clinical study.

Arash Khojasteh1,2, Sepanta Hosseinpour2, Maryam Rezai Rad1, Marzieh Alikhasi3, Homayoun H Zadeh4.   

Abstract

BACKGROUND: Application of adipose-derived stem cells originated from buccal fat pad (BFP) can simplify surgical procedures and diminish clinical risks compared to large autograft harvesting.
PURPOSE: This study sought to evaluate and compare the efficacy of buccal fat pad-derived stem cells (BFPSCs) in combination with anorganic bovine bone mineral (ABBM) for vertical and horizontal augmentation of atrophic posterior mandibles.
MATERIALS AND METHODS: Fourteen patients with atrophic posterior mandible were elected for this prospective exploratory study. BFP (3-5 mL) was harvested and BFPSCs were isolated and combined with ABBM at 50% ratio. The vertical and horizontal alveolar deficiencies were augmented by 50% mixture of ABBM with either BFPSCs (group 1) or particulated autologous bone (group 2). Titanium mesh was contoured to the desired 3D shape of the alveolar ridge and fixated to the host sites over the graft material of the two groups. At first, the amount of new bone areas was calculated by quantitative analysis of cone beam computed tomography (CBCT) images that were taken 6 months postoperatively according to regenerative techniques (group 1 vs group 2 without considering the type of bone defects). Second, these amounts were calculated in each group based on the type of defects.
RESULTS: Quantitative analysis of CBCT images revealed the areas of new bone formation were 169.5 ± 5.90 mm2 and 166.75 ± 10.05 mm2 in groups 1 and 2, respectively. The area of new bone formation for vertical defects were 164.91 ± 3.74 mm2 and 169.36 ± 12.09 mm2 in groups 1 and 2, respectively. The area of new bone formation for horizontal deficiencies were 170.51 ± 4.54 mm2 and 166.98 ± 9.36 mm2 in groups 1 and 2, respectively. There were no statistically significant differences between the two groups in any of the pair-wise comparisons (P > 0.05).
CONCLUSIONS: The findings of the present study demonstrated lack of difference in bone volume formation between BFPSCs and autologous particulate bone in combination with ABBM. If confirmed by future large-scale clinical trial, BFPSCs may provide an alternative to autogenous bone for reconstruction of alveolar ridge defects.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Tissue Engineering; alveolar ridge augmentation; atrophic posterior mandible; buccal fat pad-derived stem cells; mesenchymal stem cells; osteogenesis

Mesh:

Substances:

Year:  2019        PMID: 30821120     DOI: 10.1111/cid.12729

Source DB:  PubMed          Journal:  Clin Implant Dent Relat Res        ISSN: 1523-0899            Impact factor:   3.932


  4 in total

1.  Buccal Fat Pad Graft in Maxillofacial Surgery.

Authors:  Amin Rahpeyma; Saeedeh Khajehahmadi
Journal:  Indian J Surg Oncol       Date:  2021-09-08

2.  Vertical and horizontal ridge augmentation using customized CAD/CAM titanium mesh with versus without resorbable membranes. A randomized clinical trial.

Authors:  Alessandro Cucchi; Elisabetta Vignudelli; Debora Franceschi; Emanuele Randellini; Giuseppe Lizio; Antonino Fiorino; Giuseppe Corinaldesi
Journal:  Clin Oral Implants Res       Date:  2021-10-13       Impact factor: 5.021

3.  Use of buccal fat pad-derived stem cells cultured on bioceramics for repair of critical-sized mandibular defects in healthy and osteoporotic rats.

Authors:  Fabio Camacho-Alonso; M R Tudela-Mulero; J A Navarro; A J Buendía; A M Mercado-Díaz
Journal:  Clin Oral Investig       Date:  2022-05-07       Impact factor: 3.606

4.  Isolation and Characterization of Buccal Fat Pad and Dental Pulp MSCs from the Same Donor.

Authors:  Tullio Genova; Davide Cavagnetto; Fabio Tasinato; Sara Petrillo; Federico Alessandro Ruffinatti; Luca Mela; Massimo Carossa; Luca Munaron; Ilaria Roato; Federico Mussano
Journal:  Biomedicines       Date:  2021-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.